Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Plos Pathogens
|
April 24, 2024
Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites
Laura Dirkx, Sara I Van Acker, Yasmine Nicolaes, et al.
Plos One
|
April 29, 2016
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
Annelies Mondelaers, Maria P Sanchez-Cañete, Sarah Hendrickx, et al.
Natural Product Research
|
February 10, 2018
Report of <i>in vitro</i> antileishmanial properties of Iberian macroalgae
Carolina Bruno de Sousa, João Henrique G Lago, Jorge Macridachis, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
The Journal of Antimicrobial Chemotherapy
|
May 11, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Nature Communications
|
February 27, 2024
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
Benoit Stijlemans, Patrick De Baetselier, Inge Van Molle, et al.
Science Translational Medicine
|
December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>
Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Plos Pathogens
|
April 24, 2024
Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites
Laura Dirkx, Sara I Van Acker, Yasmine Nicolaes, et al.
Plos One
|
April 29, 2016
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
Annelies Mondelaers, Maria P Sanchez-Cañete, Sarah Hendrickx, et al.
Natural Product Research
|
February 10, 2018
Report of <i>in vitro</i> antileishmanial properties of Iberian macroalgae
Carolina Bruno de Sousa, João Henrique G Lago, Jorge Macridachis, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
The Journal of Antimicrobial Chemotherapy
|
May 11, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Nature Communications
|
February 27, 2024
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
Benoit Stijlemans, Patrick De Baetselier, Inge Van Molle, et al.
Science Translational Medicine
|
December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>
Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.
Page
of 5